# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
PubMatic (NASDAQ:PUBM), an independent technology company delivering digital advertising's supply chain of the future, toda...
Eroxon® is Haleon's first offering in the sexual health space Clinical studies show Eroxon® is safe and effective in men wi...
Updating guidance for FY2024 and confident of delivery on medium term guidance ● Organic revenue growth expected to be 4-6% ● ...
Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories SA for £50...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol an...
Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.